Company intelligence / Profile preview

Vista Ophthalmics

Houston/Katy, Texas, United Statesvistaophthalmics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vista Ophthalmics has developed two key products—Vista 1-Step and Vista IS—designed to improve efficiency and safety in ophthalmic surgery. The company has entered an exclusive global partnership with Microsurgical Technology (MST) to commercialize these products. The first U.S. launch will be at the American Academy of Ophthalmology conference in October 2024, with international rollout planned thereafter[5][6].

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Microsurgical Technology (MST)

Beyond the preview

Go deeper on Vista Ophthalmics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vista Ophthalmics.

Explore the full profile